As evidenced in mouse, the levels of ZEB1 are in general statistically lower than ZEB2 in primary AML cells, with the translocation driver mutation likely affecting the expression of these transcription factors (S11A Fig, left and right, respectively: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). The gene discussed is ZEB2; the disease is acute myeloid leukemia.